Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Skye Bioscience Inc (SKYE)

Skye Bioscience Inc (SKYE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.5900 -0.2800 (-14.97%) 03/31/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.6600 +0.0700 (+4.40%) 16:09 ET
Quote Overview for Mon, Mar 31st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.5600
Day High
1.8500
Open 1.8100
Previous Close 1.8700 1.8700
Volume 455,100 455,100
Avg Vol 205,400 205,400
Stochastic %K 12.09% 12.09%
Weighted Alpha -78.89 -78.89
5-Day Change -0.7600 (-32.34%) -0.7600 (-32.34%)
52-Week Range 1.5600 - 17.6473 1.5600 - 17.6473
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 57,923
  • Shares Outstanding, K 30,975
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,570 K
  • EBIT $ -30 M
  • EBITDA $ -29 M
  • 60-Month Beta 1.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.94

Options Overview Details

View History
  • Implied Volatility 301.85% ( +120.45%)
  • Historical Volatility 112.53%
  • IV Percentile 52%
  • IV Rank 37.91%
  • IV High 783.06% on 12/20/24
  • IV Low 8.06% on 09/16/24
  • Put/Call Vol Ratio 15.00
  • Today's Volume 16
  • Volume Avg (30-Day) 33
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 1,157
  • Open Int (30-Day) 1,426

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.31
  • Number of Estimates 2
  • High Estimate -0.26
  • Low Estimate -0.35
  • Prior Year -0.18
  • Growth Rate Est. (year over year) -72.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5600 +1.92%
on 03/31/25
Period Open: 2.8500
2.9200 -45.55%
on 03/03/25
-1.2600 (-44.21%)
since 02/28/25
3-Month
1.5600 +1.92%
on 03/31/25
Period Open: 2.4600
4.2500 -62.59%
on 01/31/25
-0.8700 (-35.37%)
since 12/27/24
52-Week
1.5600 +1.92%
on 03/31/25
Period Open: 15.6400
17.6473 -90.99%
on 04/18/24
-14.0500 (-89.83%)
since 03/28/24

Most Recent Stories

More News
Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

SKYE : 1.5900 (-14.97%)
Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025

SKYE : 1.5900 (-14.97%)
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SKYE : 1.5900 (-14.97%)
Is This Penny Stock’s 525% Upside Potential an Attainable Goal?

Skye Bioscience is trying to establish a presence in the weight-loss drug market.

SKYE : 1.5900 (-14.97%)
NVO : 69.44 (+1.82%)
$SPX : 5,611.85 (+0.55%)
LLY : 825.91 (+0.41%)
Skye Bioscience to Participate in SXSW Session on Obesity

SKYE : 1.5900 (-14.97%)
Skye Bioscience to Present at TD Cowen Health Care Conference

SKYE : 1.5900 (-14.97%)
Skye Bioscience Announces Participation in February Conferences

SKYE : 1.5900 (-14.97%)
Skye Bioscience Provides 2025 Look Ahead and Year in Review

SKYE : 1.5900 (-14.97%)
Skye Bioscience to Present Corporate Overview at 43rd Annual J.P. Morgan Healthcare Conference

Skye Bioscience will present its corporate overview and Phase 2 trial results at the J.P. Morgan Healthcare conference.Quiver AI SummarySkye Bioscience, Inc. announced that it will present a corporate...

SKYE : 1.5900 (-14.97%)
Skye Bioscience to Present at J.P. Morgan Healthcare Conference

SKYE : 1.5900 (-14.97%)

Business Summary

Skye Bioscience Inc. is a biopharmaceutical company. It is focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need. Skye Bioscience Inc., formerly known as Emerald Bioscience Inc., is based in San Diego, Calif.

See More

Key Turning Points

3rd Resistance Point 2.0633
2nd Resistance Point 1.9567
1st Resistance Point 1.7733
Last Price 1.5900
1st Support Level 1.4833
2nd Support Level 1.3767
3rd Support Level 1.1933

See More

52-Week High 17.6473
Fibonacci 61.8% 11.5020
Fibonacci 50% 9.6037
Fibonacci 38.2% 7.7053
Last Price 1.5900
52-Week Low 1.5600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies